|
Merz Pharmaceuticals is specialized in the research and development of innovative pharmaceutical products in the area of neurological, psychiatric and dermatological diseases.
Merz Pharmaceuticals is a leader in the field of Alzheimer’s disease research and has developed the world’s first drug for the treatment of moderate to severe stages of Alzheimer’s disease. Merz Pharmaceuticals has also developed drugs for the treatment of Parkinson’s disease and depression.
Merz Pharmaceuticals dermatology products are aimed on the treatment of scars, acne, hair loss and fungal disease.
Merz Pharma UK is a subsidiary of Merz Pharmaceuticals and is currently focused on treatments in both neurological and psychiatric conditions.
|